Skip to main content

Project Title

Assessing the Lifetime Economic Burden in Younger, Midlife, and Older Women with Metastatic Breast Cancer

Funding Dates



The economic cost data produced by this study will help decision-makers allocate scarce public health resources more effectively for the prevention and treatment of metastatic breast cancer (mBC). For example, the cost projections can highlight cost drivers for women with mBC and motivate population-level prevention, early detection, and timely treatment activities. This study is also identifying cost-effective treatment pathways to improve the quantity and quality of life among women of all ages with mBC to ensure that women with mBC receive high-quality care while minimizing the economic impact on patients and payers. In addition, findings can be used to support value-based pathway driven treatment decisions and inform policymaking.

Research Areas 

Cancer Prevention and Control

Principal Investigator

Stephanie Wheeler, PhD, MPH and Justin Trogdon, PhD


Centers for Disease Control and Prevention